Hofseth Biocare ASA - Company Profile
Powered by 
All the data and insights you need on Hofseth Biocare ASA in one report.
$295
- Save hours of research time and resources with
our up-to-date Hofseth Biocare ASA Strategy Report
- Understand Hofseth Biocare ASA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Hofseth Biocare ASA (HBC) is a developer, manufacturer, marketer and seller of marine ingredients-based products. The company's product portfolio comprises of salmon oil capsules, soluble salmon protein hydrolysate powder, non-soluble proteins, marine calcium bone powders, and collagen peptides. HBC also provides insurance services. It markets product under OmeGo, ProGo, and CalGo brand names. The company sells its products to various segments of the human nutrition market such as sports nutrition, supplements, and health food, and to the market in nutrition for the pet and feed industry. It has operations across Asia, North America, and Europe. Hofseth Biocare is headquartered in Alesund, Norway.
Headquarters
Norway
Address
Kipervikgata 13, Alesund, 6003
Website
hofsethbiocare.com
Telephone
47 73 102200
No of Employees
62
Industry
Consumer Packaged Goods
Ticker Symbol & Exchange
HBC (OSL)
Revenue (2022)
$20.7M
81.4%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
22.4%
(2022 vs 2021)
Market Cap*
$75.8M
Net Profit Margin (2022)
XYZ
57.2%
(2022 vs 2021)
* As of and is in US$
Products and Services
| Products | Services | Brands |
|---|---|---|
| Salmon Oil | Insurance Services | : |
| Soluble Protein Hydrolysate Powder | OmeGo | |
| Calcium Bone Powder | ProGo | |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Plans/Strategy | In May, the company announced its plans to transfer its prostate cancer co-treatment project to a new US entity to be called HBC Immunology Inc. |
| 2021 | Contracts/Agreements | In May, the company entered into a partnership with Catalent to develop a delayed-release formulation of HBC’s OmeGo fish oil. |
| 2021 | Contracts/Agreements | In April, the company extended its agreements with IMCD for its marine branded products |
Competitor Comparison
| Key Parameters | Hofseth Biocare ASA | Aker BioMarine AS | Arctic Bioscience AS | Astareal AB | Norwegian Fish Oil AS |
|---|---|---|---|---|---|
| Headquarters | Norway | Norway | Norway | Sweden | Norway |
| City | Alesund | Lysaker | Orsta | Stockholm | - |
| State/Province | - | - | - | Stockholm | - |
| No. of Employees | 62 | 373 | - | - | - |
| Entity Type | Public | Public | Public | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Kristin Fjellby Grung | Chairman | Executive Board | 2022 | - |
| Jon Olav Odegard | Chief Executive Officer | Senior Management | 2022 | - |
| Christel Elise Kanli | Chief Financial Officer; Chief Operating Officer | Senior Management | 2023 | - |
| Bomi Framroze | Chief Scientific Officer | Senior Management | 2009 | - |
| James Berger | Chief Commercial Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer